Reuters, Thursday January 19 2012 * Sees EBITDA of 420-430 mln shekels including class action
* Expects net profit of 70-80 mln including one-off items
* Plans to raise up to 300 mln shekels in debt offering (Adds details on Q4 outlook, background)
TEL AVIV, Jan 19 (Reuters) - Israel's largest mobile phone operator Cellcom said its fourth-quarter profit would be sharply lower after regulators clipped the fees they make and due to one-off costs including a lawsuit from customers.
Efficiency measures and synergies it expects from its acquisition of Internet service provider Netvision are not yet reflected in the fourth-quarter results, it said on Thursday.
Cellcom also said it was planning to raise up to 200 million to 300 million shekels ($53 million-$79 million) in a public debt offering in Israel.
The company estimated earnings before interest, tax, depreciation and amortisation (EBITDA) including Netvision for the quarter will be 440 million to 450 million shekels before the effect of a class-action lawsuit and 420 million to 430 million after it. Cellcom is appealing against the court order that it should repay customers charges it implemented for providing call details records, having previously provided them for free.
In the year-ago quarter Cellcom had EBITDA of 631 million shekels and adjusted EBITDA of 682 million.
Net income will also be affected by a previously announced deferred tax expense following the increase in corporate taxes. Net income before the lawsuit and deferred tax liability is estimated to be 120 million to 130 million shekels, and 70 million to 80 million afterwards.
In the fourth quarter of 2010 Cellcom posted net profit of 319 million shekels and adjusted net profit of 348 million.
Cellcom's Tel Aviv listed shares were down 1.7 percent at 60.25 shekels in late trading, compared with gains of 0.5 percent on the broader market.
Cellcom plans to use the proceeds of the debt offering, if executed, for general corporate purposes, which might include financing its operating and investment activity, refinancing of outstanding debt and continued dividend distribution.
Cellcom and rivals Partner and Bezeq unit Pelephone were hit at the start of 2011 by a steep reduction in fees mobile operators charge each other to connect calls and the elimination of exit fines for customers. The regulatory changes hurt profits at the three companies in 2011. ($1 = 3.78 shekels) (Reporting by Tova Cohen; Editing by Steven Scheer)
© 2012 Guardian News and Media Limited or its affiliated companies
Recent CEL News
- Celadon Pharmaceuticals PLC Result of AGM • RNS Regulatory News • 06/28/2024 06:00:12 AM
- Celadon Pharmaceuticals PLC Second Admission of Shares • RNS Regulatory News • 06/07/2024 06:00:09 AM
- No Headline Available • Alliance News • 06/03/2024 05:01:12 PM
- Celadon Pharmaceuticals PLC Publication of Annual Report & Notice of AGM • RNS Regulatory News • 06/03/2024 04:45:01 PM
- Celadon ships to US; Oxford BioDynamics-Goodbody pact • Alliance News • 05/23/2024 08:08:53 PM
- Celadon Pharmaceuticals PLC Supply of Products to New US Customer • RNS Regulatory News • 05/23/2024 06:00:13 AM
- Celadon Pharmaceuticals PLC Exercise of Share Options and Total Voting Rights • RNS Regulatory News • 05/15/2024 01:45:01 PM
- Headlam warns of loss; EnSilica predicts revenue rise • Alliance News • 05/14/2024 06:41:32 PM
- Celadon Pharmaceuticals PLC Final Results • RNS Regulatory News • 05/14/2024 06:00:12 AM
- Celadon raises GBP2 million, extends credit facility • Alliance News • 05/10/2024 05:57:23 PM
- Celadon Pharmaceuticals PLC Fundraise, RCF Extension, Termination of CLN & TVR • RNS Regulatory News • 05/10/2024 06:00:08 AM
- Celadon hails early results of chronic pain trial • Alliance News • 03/08/2024 08:04:45 PM
- Celadon Pharmaceuticals PLC Early Economic Analysis of Feasibility Study Data • RNS Non-Regulatory • 03/07/2024 07:00:13 AM
- Celadon announces start of cannabis supply for two UK companies • Alliance News • 12/14/2023 02:18:53 PM
- Celadon Pharmaceuticals PLC Product Supplied to First Two Sales Contracts • UK Regulatory • 12/14/2023 07:00:00 AM
- Celadon Pharma raises GBP2.0 million via placing • Alliance News • 12/12/2023 05:40:04 PM
- Celadon Pharmaceuticals PLC Fundraise, Update on Future CLN Financing & TVR • UK Regulatory • 12/12/2023 02:00:00 PM
- Celadon shares rise on supply contract worth up to GBP26 million • Alliance News • 11/16/2023 11:45:35 AM
- Celadon Pharmaceuticals PLC New European Sales Contract • UK Regulatory • 11/16/2023 07:00:00 AM
- Celadon Pharmaceuticals raises GBP1.0 million through shares • Alliance News • 10/13/2023 02:42:26 PM
- Celadon Pharmaceuticals PLC Fundraise, CLN Issue, Joint Broker Appointed & TVR • UK Regulatory • 10/13/2023 06:00:00 AM
- Celadon Pharmaceuticals interim loss narrows; optimistic for future • Alliance News • 09/28/2023 11:14:47 AM
- Celadon Pharmaceuticals PLC Interim Results • UK Regulatory • 09/28/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC Notice of Results and Investor Presentation • UK Regulatory • 09/18/2023 06:00:00 AM
- Celadon shares rise on second UK contract win for cannabis product • Alliance News • 09/05/2023 09:48:42 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM